The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)

Abstract Background Urinary system resections are performed during the cytoreductive surgery with hypertermic intraperitoneal chemotherapy (CRS-HIPEC). However, isolated ureter resection and reconstruction results are uncertain. The aim of this study was to evaluate the postoperative outcomes of iso...

Full description

Bibliographic Details
Main Authors: Şevket Barış Morkavuk, Murat Güner, Mesut Tez, Ali Ekrem Ünal
Format: Article
Language:English
Published: BMC 2019-12-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:https://doi.org/10.1186/s12957-019-1770-x
_version_ 1819074212924489728
author Şevket Barış Morkavuk
Murat Güner
Mesut Tez
Ali Ekrem Ünal
author_facet Şevket Barış Morkavuk
Murat Güner
Mesut Tez
Ali Ekrem Ünal
author_sort Şevket Barış Morkavuk
collection DOAJ
description Abstract Background Urinary system resections are performed during the cytoreductive surgery with hypertermic intraperitoneal chemotherapy (CRS-HIPEC). However, isolated ureter resection and reconstruction results are uncertain. The aim of this study was to evaluate the postoperative outcomes of isolated ureteral resection and reconstructions in patients who underwent CRC and HIPEC procedure. Methods A total of 257 patients that underwent CRC and HIPEC between 2015 and 2017 in the Department of Surgical Oncology, Faculty of Medicine, Ankara University, were retrospectively analyzed. Twenty patients that had undergone isolated ureteral resection and reconstruction were included in the study. Predisposing factors were investigated in patients who developed postoperative complications. Results The mean age of the patients was 55.1 years. The mean follow-up time of all the patients was 11.6 months. Postoperative mortality occurred in two patients. The mean PCI score was 13.9. Postoperative urologic complications were observed in eight patients after ureter reconstruction. There was no statistically significant difference between the groups in terms of reconstruction techniques and postoperative complications (P = 302). There was no correlation between age (P = 0.571) and gender (P = 0.161) with complications. CRS-HIPEC was performed mostly due to gynecologic malignancy. However, there was no correlation between the primary cancer diagnosis and the development of complications (P = 0.514). The hospital stay duration was higher in the group with complications (16.3 vs 8.8 days, P = 0.208). Conclusions Ureteral resections and reconstructions can be performed for R0/1 resections in CRS-HIPEC operations. It leads to an increase in hospital stay. But there is no significant difference in the development of complications. In the management of complications, conservative approach was sufficient.
first_indexed 2024-12-21T18:05:56Z
format Article
id doaj.art-9658e07d84164a4a80a971b212bd8f93
institution Directory Open Access Journal
issn 1477-7819
language English
last_indexed 2024-12-21T18:05:56Z
publishDate 2019-12-01
publisher BMC
record_format Article
series World Journal of Surgical Oncology
spelling doaj.art-9658e07d84164a4a80a971b212bd8f932022-12-21T18:54:56ZengBMCWorld Journal of Surgical Oncology1477-78192019-12-011711710.1186/s12957-019-1770-xThe outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)Şevket Barış Morkavuk0Murat Güner1Mesut Tez2Ali Ekrem Ünal3Department of Surgical Oncology, Ankara City Hospital, Üniversiteler MahallesiDepartment of General Surgery, Usak Research and Training HospitalDepartment of Surgical Oncology, Ankara City Hospital, Üniversiteler MahallesiDepartment of Surgical Oncology, Ankara University Faculty of MedicineAbstract Background Urinary system resections are performed during the cytoreductive surgery with hypertermic intraperitoneal chemotherapy (CRS-HIPEC). However, isolated ureter resection and reconstruction results are uncertain. The aim of this study was to evaluate the postoperative outcomes of isolated ureteral resection and reconstructions in patients who underwent CRC and HIPEC procedure. Methods A total of 257 patients that underwent CRC and HIPEC between 2015 and 2017 in the Department of Surgical Oncology, Faculty of Medicine, Ankara University, were retrospectively analyzed. Twenty patients that had undergone isolated ureteral resection and reconstruction were included in the study. Predisposing factors were investigated in patients who developed postoperative complications. Results The mean age of the patients was 55.1 years. The mean follow-up time of all the patients was 11.6 months. Postoperative mortality occurred in two patients. The mean PCI score was 13.9. Postoperative urologic complications were observed in eight patients after ureter reconstruction. There was no statistically significant difference between the groups in terms of reconstruction techniques and postoperative complications (P = 302). There was no correlation between age (P = 0.571) and gender (P = 0.161) with complications. CRS-HIPEC was performed mostly due to gynecologic malignancy. However, there was no correlation between the primary cancer diagnosis and the development of complications (P = 0.514). The hospital stay duration was higher in the group with complications (16.3 vs 8.8 days, P = 0.208). Conclusions Ureteral resections and reconstructions can be performed for R0/1 resections in CRS-HIPEC operations. It leads to an increase in hospital stay. But there is no significant difference in the development of complications. In the management of complications, conservative approach was sufficient.https://doi.org/10.1186/s12957-019-1770-xUreteral resectionCytoreductive surgeryHIPEC
spellingShingle Şevket Barış Morkavuk
Murat Güner
Mesut Tez
Ali Ekrem Ünal
The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)
World Journal of Surgical Oncology
Ureteral resection
Cytoreductive surgery
HIPEC
title The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)
title_full The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)
title_fullStr The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)
title_full_unstemmed The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)
title_short The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)
title_sort outcomes of isolated ureteral resection and reconstruction in non urologic cancer patients who underwent cytoreductive surgery crc and hyperthermic intraperitoneal chemotherapy hipec
topic Ureteral resection
Cytoreductive surgery
HIPEC
url https://doi.org/10.1186/s12957-019-1770-x
work_keys_str_mv AT sevketbarısmorkavuk theoutcomesofisolatedureteralresectionandreconstructioninnonurologiccancerpatientswhounderwentcytoreductivesurgerycrcandhyperthermicintraperitonealchemotherapyhipec
AT muratguner theoutcomesofisolatedureteralresectionandreconstructioninnonurologiccancerpatientswhounderwentcytoreductivesurgerycrcandhyperthermicintraperitonealchemotherapyhipec
AT mesuttez theoutcomesofisolatedureteralresectionandreconstructioninnonurologiccancerpatientswhounderwentcytoreductivesurgerycrcandhyperthermicintraperitonealchemotherapyhipec
AT aliekremunal theoutcomesofisolatedureteralresectionandreconstructioninnonurologiccancerpatientswhounderwentcytoreductivesurgerycrcandhyperthermicintraperitonealchemotherapyhipec
AT sevketbarısmorkavuk outcomesofisolatedureteralresectionandreconstructioninnonurologiccancerpatientswhounderwentcytoreductivesurgerycrcandhyperthermicintraperitonealchemotherapyhipec
AT muratguner outcomesofisolatedureteralresectionandreconstructioninnonurologiccancerpatientswhounderwentcytoreductivesurgerycrcandhyperthermicintraperitonealchemotherapyhipec
AT mesuttez outcomesofisolatedureteralresectionandreconstructioninnonurologiccancerpatientswhounderwentcytoreductivesurgerycrcandhyperthermicintraperitonealchemotherapyhipec
AT aliekremunal outcomesofisolatedureteralresectionandreconstructioninnonurologiccancerpatientswhounderwentcytoreductivesurgerycrcandhyperthermicintraperitonealchemotherapyhipec